SITC Cancer Immunotherapy CONNECT


Provide Feedback on the 
"Society for Immunotherapy of Cancer Consensus Statement on Immunotherapy for the Treatment of Cutaneous Melanoma: Version 2.0."*

member-ribbon-v4.pngOpen Comment period ends January 5, 2018 at 5 p.m. ET.
*Available to SITC members current in their dues.

Learn More

Register Now for Jan. 19 ACI Program in Atlanta

Attend SITC's upcoming Advances in Cancer Immunotherapy™ (ACI) program on Jan. 19 in Atlanta to learn clinical applications of immunotherapy for disease states with FDA-approved treatments and much more.

Register Today for Atlanta


Access Scientific Highlights and More from the 32nd Annual Meeting

Review SITC's coverage from National Harbor, Md. for the 32nd Annual Meeting, visit The Sentinel, SITC's official blog, to read scientific highlights, view daily photo galleries and much more.

Read SITC 2017 Coverage


Learn About the Awarded Projects of the SITC Sparkathon

Projects of the 2017 SITC Sparkathon have been announced! Learn more about teams TimIOs and the METIOR Incubator, and see how you can support and become involved in the efforts of these talented young investigators.



Bookmark The Sentinel, SITC's New Official Blog

The Society for Immunotherapy of Cancer (SITC) is excited to announce the launch of its official blog, The Sentinel! Dedicated to providing SITC members a voice to share their expertise, The Sentinel will feature informational posts for the entire cancer immunotherapy community – from patients to clinicians to researchers.

Learn More


New to SITC connectED: Advances in Cancer Immunotherapy™ 2017 Video Series

Now in the SITC connectED Class Catalog, register for the Advances in Cancer Immunotherapy™ 2017 Video Series. This free online class will facilitate understanding of the clinical applications of immunotherapy for disease states with FDA-approved treatments, strategies for overcoming operational and reimbursement barriers and much more.

Register for the Class


The Authoritative Cancer Immunotherapy Reference

SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*

member-ribbon-v4.png*Available only when ordering from Demos Medical Publishing. Cannot be combined with any other offers.

Learn More

Clinical Advances in Cancer Immunotherapy Online Portal

In partnership with Medscape Oncology, SITC offers a robust online learning portal designed to provide clinical oncologists with free, CME-/CE-certified education in the immunotherapy field.

Learn More


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • Profile Picture

    onset of effect - Opdivo treatment

    This message was posted by a user wishing to remain anonymous Hi All  His is an attempt to find answers on the observed onset of effect on Opdivo / Nivolumab treatment. If you are a doctor having experience with this treatment I would be eager to hear ...

  • What's new in immuno-oncology? Discover the latest advancements in combination immunotherapy in this interview with James Gulley in which he provides insider details of the Phase I trial for M7824.  ...

  • The publication yesterday of  the first clinical guidelines  by the Society for Immunotherapy of Cancer on management of side effects associated with immunotherapies really felt momentous. We've been talking about these issues for a couple of years ...

    1 person recommends this.

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


Publications & Resources

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More